Neogen Chemicals to hold EGM on March 29, 2026, for Preferential Issue
Neogen Chemicals will hold an EGM on March 29, 2026, to approve a preferential issue of 10,00,000 equity shares at ₹1,610 each to Cadamba Solutions Private Limited. The issue aims to raise ₹161 crore. Remote e-voting is available from March 26-28, 2026.
The preferential issue involves a significant amount of capital, which could impact the company's capital structure and shareholder value. The involvement of the promoter group suggests strategic importance.
The announcement is positive as it details a preferential share issuance to a promoter group member, indicating a capital raise and potential for growth or strategic alignment. The clear dates and procedures for the EGM and e-voting provide transparency.
Neogen Chemicals Limited has announced an Extra Ordinary General Meeting (EGM) to be held on Sunday, March 29, 2026, at 11:30 a.m. IST through video conferencing and other audio-visual means.
The primary purpose of the EGM is to seek shareholder approval for a preferential issue of 10,00,000 equity shares of face value ₹10 each, at an issue price of ₹1,610 per share (including a premium of ₹1,600 per share). This issuance, aggregating ₹1,61,00,00,000 (₹161 crore), is proposed to be made to Cadamba Solutions Private Limited, a promoter group member, for cash consideration.
The company has set Friday, March 20, 2026, as the cut-off date for determining eligibility to vote on the resolutions. The register of members and share transfer books will be closed from Saturday, March 21, 2026, to Sunday, March 29, 2026, inclusive. E-voting will commence on Thursday, March 26, 2026, at 9:00 a.m. IST and conclude on Saturday, March 28, 2026, at 5:00 p.m. IST for remote e-voting. E-voting will also be available during the EGM. The notice of the EGM, dated March 7, 2026, is being sent to members via email and is accessible on the company's and stock exchanges' websites.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under egm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.